Adjuvant treatment of pancreatic cancer (Q37937922)

25 August 2017

1 reference

title

Adjuvant treatment of pancreatic cancer. (English)

1 reference

25 August 2017

1 reference

John P Neoptolemos

1

1 reference

25 August 2017

1 September 2011

1 reference

European Journal of Cancer

25 August 2017

1 reference

25 August 2017

47 Suppl 3

1 reference

25 August 2017

S378-80

1 reference

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

25 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970210-6

7 January 2021

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970210-6

7 January 2021

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970210-6

7 January 2021

Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer-Subset analysis of the ESPAC-1 data

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970210-6

7 January 2021

Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater--results of a controlled, prospective, randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970210-6

7 January 2021

Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970210-6

7 January 2021

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970210-6

7 January 2021

Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970210-6

7 January 2021

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970210-6

7 January 2021

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970210-6

7 January 2021

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970210-6

7 January 2021

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970210-6

7 January 2021

Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970210-6

7 January 2021

Adjuvant chemoradiation for pancreatic cancer: few good data, much debate

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970210-6

7 January 2021

Refinement of adjuvant therapy for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970210-6

7 January 2021

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970210-6

7 January 2021

10.1016/S0959-8049(11)70210-6

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21944022